Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $12450 in 2022. In 2022 we received donations from third parties of $7671 until 08/31. Unfortunately, 99.7% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2022 would be over after a few days. This donation request is displayed 4,000 times a week, but only 19 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$7671 of $12450 - as of 2022-09-02
61%
Header Image
1. Prenatal stressors as ADHD environmental causes

1. Prenatal stressors as ADHD environmental causes

Even before birth, the unborn child can be damaged by toxic influences from the mother.
Maternal stress during pregnancy increases the child’s ADHD risk by 72%.1

Children with ADHD were more likely to have mothers who had health conditions during pregnancy:2

  • Maternal diseases during pregnancy:
    In 34.4% of children with ADHD(H)S, the mother had a condition during pregnancy, compared to 14.4% of non-affected children
    • Children with ADHD: 34.7 %
      Diseases of the mother in pregnancy were in the following trimester
      • 1st/2nd trimester only: 56.4 %
      • 3rd trimester only: 12.7 %
      • Total pregnancy: 30.9
    • Non-affected children: 14.4 %
      Diseases of the mother in pregnancy were in the following trimester
      • 1st/2nd trimester only: 0%
      • 3rd trimester only: 33.3 %
      • Total pregnancy: 66.7
  • Other pregnancy problems
    • Children with ADHD: 14.5 %
    • Non-affected children: 3.8 %

Basically, psychological stress and physical stress (toxins, diseases) have a comparable effect on the stress systems (HPA axis, autonomic nervous system and others).
In addition, toxins can impair the dopaminergic system of the offspring even before conception. See Excursus: Nicotine consumption by the father before conception: epigenetic inheritance of nicotine damage.

Although the following collection is extensive, quite a few other circumstances are likely to be associated with an increased risk of ADHD.

1.1 Toxins during pregnancy as risks for ADHD

Toxic effects to unborn children have been demonstrated for:

1.1.1. Mother’s nicotine consumption during pregnancy (+ 90 to 170%)

Prenatal smoking causes a 1.9-fold ADHD risk (increased by 90%)3 to 2.7-fold ADHD risk (increased by 170%)4 for the offspring. Other studies also found significantly increased risk scores.5678

Children with ADHD were more likely to have mothers who had smoked during pregnancy:29

  • Children with ADHD: 27.3 %
  • Non-affected children: 8.5 %

Only two studies (with overlapping authors) and one metastudy reached a different conclusion.101112

Most experiments with prenatal nicotine exposure show a decrease in dopamine levels in the PFC and striatum. Under certain circumstances, increased dopamine levels were also shown.13 ADHD is neurophysiologically closely associated with decreased dopamine levels in the dlPFC (impaired working memory) and striatum (impaired motivation and motor control = hyperactivity).
To be distinguished from this is smoking by affected persons - this increases dopamine levels (at least in the striatum), as it reduces DAT, which is too pronounced in ADHD and reduces dopamine levels in the striatum. Acute smoking thus increases dopamine levels in the striatum.

Prenatal smoking in combination with certain gene polymorphisms increases ADHD probability more than when these genetic risks are not present:

  • If there are no genetic risks, smoking by the mother during pregnancy increases the ADHD risk for the child by 20 to 30%.
  • The risk genes alone (if the mother does not smoke during pregnancy) increase the risk by 20% to 40%.
  • However, if risk genes and maternal smoking coincide during pregnancy, the child’s risk of ADHD increases many times over
    • DAT1-9R (440 bp): by 2.6 times
    • DRD4-7R by 2.9 times
    • Both together by a factor of 9.1415
      Another study confirms the involvement of DRD4-7R in gene-environment interactions.16
  • Smoking by the mother during pregnancy increased the risk of hyperactivity/impulsivity symptoms in the child by 50%.17 Passive smoking already increased this risk by almost 50%, but only for boys.

Maternal smoking during pregnancy alters glutamate NMDA receptors in the laterodorsal tegmentum of the offspring.18 Another study also found changes in glutamatergic signaling in the hippocampus due to increased glutamate receptor expression,19 which was associated with learning problems, attention problems, and increased impulsivity.
ProBDNF proteolysis is impaired by an imbalance between proBDNF and BDNF and downregulation of the proBDNF processing enzyme furin. Glucocorticoid receptor activity is altered by decreased relative nuclear GR localization. Basal plasma corticosterone levels are decreased. The HPA axis is impaired. This affects the offspring themselves, but also their children, so it is inherited.20

In rodents, prenatal nicotine exposure has been found to decrease dopamine levels in the offspring mPFC.21 In ADHD, dopamine levels in the PFC are decreased.

A study of mice whose mothers were exposed to nicotine during pregnancy found evidence that nicotine causes several consequences during pregnancy that persisted in the grandchild generation, suggesting epigenetic heritability:22

  • Deficits in the expression of corticostriatal DNA methyltransferase 3A (DNMT3A)
  • Downregulation of methyl CpG-binding protein 2 (MeCP2) in frontal cortices and hippocampus
  • Downregulation of histone deacetylase 2 (HDAC2) in frontal cortices and hippocampus
  • Abnormalities in HDAC2 (Ser394) phosphorylation in frontal cortices, striatum, and hippocampus
  • No change in ten-eleven translocase methylcytosine dioxygenase 2 (TET2) expression
  • No abnormalities in MeCP2 (Ser421) phosphorylation in frontal cortices, striatum, and hippocampus

Even passive smoking, i.e. passive exposure of the mother to nicotine smoke during pregnancy, tends to increase the risks of the unborn for later ADHD symptoms.17
Similar results were found for the causation of dyspraxia (Developmental Coordination Disorder) by secondhand smoke.23

Over 70 million women in the EU smoke during pregnancy.19

1.1.1.1. Excursus: nicotine use by a parent before conception: epigenetic inheritance of nicotine damage

Nicotine use by one parent before conception: epigenetic inheritance of nicotine damage causes ADHD symptoms in offspring over several generations

Mice whose fathers or mothers were chronically exposed to nicotine before conception, whereas the mothers had no drug exposure, showed hyperactivity, impaired nicotine-induced motor sensitization, and decreased dopamine and norepinephrine levels in the striatum and PFC.248

Nicotine use by father or mother before conception causes epigenetic changes in offspring

  • Of the dopamine D2 receptor.25
  • Of the dopamine transporter in the striatum and mPFC26
    • By downregulation of DAT expression due to increased methylation of the DAT gene.27 Increased DRD4 and 5-HT DNA methylation correlates with ADHD.28
  • Altered expression and dysfunction of nicotinic acetylcholine receptors (nAChRs)26
  • Hypersensitivity to nicotine-induced nAChR-mediated dopamine release26
  • Increases nicotine preference, triggers hyperactivity and risk-taking behavior, disrupts rhythmicity of activity, alters nAChR expression and function, impairs DAT function, and causes DNA hypomethylation in the striatum and frontal cortex of both first and second generation adolescent offspring.

The first- and second-generation children showed ADHD-typical impairments:

  1. Generation:
  • Significantly increased spontaneous locomotor activity (hyperactivity) (males and females)2526
    • Decreased DAT expression causes increased levels of dopamine in the striatum, which by means of activation of D2 receptors caused dephosphorylation of AKT, leading to increased activation of GSK3α/β and ultimately causing hyperactivity in the offspring of mice.27
  • Risk-taking behavior26
  • Significant deficits in reversal learning (males and females)25
  • Significant attention deficits (males)25
  • Significantly reduced monoamine content in the brain (males)25
  • Reduced dopamine receptor mRNA expression (males)25
  • Increased nicotine preference26
  • Activity rhythm changed26
    Note: This could be an important link to the circadianene rhythm altered in ADHD
  1. Generation:
  • Significant deficits in reversal learning (males)25
  • Hyperactivity26
  • Risk-taking behavior26
  • Increased nicotine preference26
  • Activity rhythm changed26

It can be assumed that the mechanisms take place accordingly in humans.

1.1.2. Mother’s drug use during pregnancy (+ 200%)

Children who were prenatally exposed to multiple drug use by their mothers and who subsequently grew up in residential care were found to be 3 times more likely to have ADHD between the ages of 17 and 22.29

Cannabis use during pregnancy has been associated by several studies with an increased risk of ADHD in children.30

1.1.3. Alcohol during pregnancy

Alcohol consumption by the mother during pregnancy significantly increases the ADHD probability of the children, according to various studies,3132 as well as attention problems.33 A large long-term cohort study and another study found no association.3435
A combination of alcohol and maternal stress during pregnancy increased the likelihood of developing female(r) sexual behavior in male rats.36

A metastudy found that maternal alcohol consumption of less than 70 g/week during pregnancy did not increase ADHD risk.37 Boys were less at risk than girls from alcohol during pregnancy.

A cohort study found no association between alcohol consumption (binge drinking: 1 to 3 binge drinking events; moderate drinking: 1 to 3 or more alcoholic drinks per week) in early pregnancy and ADHD risk in children aged 5 to 19 years.38

One study found a correlation between ethoxyacetic acid (one of 6 degradation products of alcohol studied) in the mother’s urine and inhibition problems in the children.39

There is evidence that alcohol consumption by the mother during pregnancy or while breastfeeding has significant effects on the child’s dopamine system.40414243 Likewise, the regulation of the neurotransmitters serotonin , glutamate, norepinephrine, acetylcholine and histamine is affected.4445 46

1.1.4. High salt consumption during pregnancy

High dietary salt intake during pregnancy could increase the stress sensitivity of the unborn baby.47

1.1.5. Lead disposition during pregnancy

Lead disposition during pregnancy4849 50 affects mesocorticolimbic circulation and increases ADHD risk in the offspring.51
Rat mothers were exposed to acute stress and lead during pregnancy. The effect on the offspring differed between lead exposure alone or lead exposure plus stress exposure. Male rat offspring showed increased corticosterone levels and decreased dopamine levels in the PFC only with lead exposure alone, and female rat offspring only with combined lead and stress exposure. Even short-term exposure of dams to lead caused this effect.52 In female rat pups, maternal lead exposure and stress contributed to learning difficulties as cumulative factors during pregnancy. These were neurophysiologically mediated through the glucocorticoid system to the mesocorticolimbic system.53

Further studies also found evidence that lead exposure, like stress during pregnancy, affects the mesocorticolimbic dopamine/glutamate system of female offspring (less so in males) and mutually increases their effects.54 Male rat offspring showed a tendency to serotonergic disturbances of the mesocorticolimbic system and altered delay discounting under similar conditions.55
Even a lead content in drinking water below the limit values is said to be problematic.49
In principle, lead water pipes are not very dangerous in areas with calcareous water, as lime forms a reliably protective layer in the pipes. However, no decalcification system for the drinking water may then be installed. Nevertheless, it is generally recommended to replace lead-containing water pipes during modernization projects.

It is possible that metabolism is altered in ADHD with respect to cobalt, copper, lead, zinc, and vanadium. Reduced cycle stability (determinism), duration (mean diagonal length) and complexity (entropy) of the exposure profiles were found.56

Lead is a divalent cation that mimics Ca2+ and activates PKC signaling.57

Arnsten58 describes lead as a toxin that causes symptoms confusable with ADHD.

Lead appears to have quite a few deleterious neurophysiological effects, including effects on the dopaminergic system:

  • Impairment of the mesocorticolimbic dopaminergic system59
  • Impairment of dopamine receptors59
  • Impairments of attentional regulation in the PFC60
  • Apoptosis61
  • Excitotoxicity61
  • Decreased cellular energy metabolism61
  • Impaired heme biosynthesis and anemia61
  • Oxidative stress61
  • Lipid peroxidation61
  • Changed activity of the Second Messenger system61
  • Altered neurotransmitter release61
  • Altered neurotransmitter receptor density61
  • Impaired neuropsychological functioning61
  • Impaired development and function of oligodendrocytes61
  • Abnormal myelin formation61
  • Abnormal neurotrophic factor expression61
  • Abnormal dendritic branching patterns61
  • Disruption of the blood-brain barrier61
  • Disruption of thyroid hormone transport to the brain61
  • Altered regulation of gene transcription61
  • Reduction of gray matter in the PFC, especially in the ACC62

Lead appears to further trigger the following behaviors:

  • Impulsivity60
  • Sociopathic behavior6364
  • Irresponsible behavior6364
  • Criminal behavior6364
  • Lower IQ61
  • Impaired academic performance61

Lead poisoning is strongly correlated with crime rates and out-of-wedlock pregnancies in the United States.6364

Children with elevated blood lead levels are said to be particularly susceptible to other toxins in early childhood.65 In particular, there have been warnings about lead in wall paint. During pregnancy, lead can be transferred from the mother to the child through the placenta.

1.1.6. Cadmium during pregnancy (+ 22 % only in girls)

Camdium exposure during pregnancy increased ADHD risk for 6-year-old girls but not for boys. Doubled maternal cadmium exposure during pregnancy increased ADHD risk for girls by 22.3%.66

1.1.7. Thallium during pregnancy

High thallium exposure in the second trimester of pregnancy increased ADHD risk for 3-year-old boys but not for girls.67

1.1.8. Pesticides during pregnancy

1.1.8.1. Organochlorine compounds contact during pregnancy

Organochlorine compounds (dichlorodiphenyltrichloroethanes (DDT), dieldrin, heptachlor, endosulfan) showed an effect on neuronal development in prenatal exposure, which (in rodents), e.g.:68

  • DAT increased
  • Dopamine reuptake increased
  • Loss of dopaminergic cells
  • Presynaptic changes in major dopaminergic proteins in response to OC pesticides in striatum or substantia nigra
  • Norepinephrine increased
  • Serotonin increased
  • GABA receptors reduced
  • NMDA receptors reduced
  • MGluR5 receptors altered
  • Altered GABAergic, glutamatergic, and dopaminergic response to endosulfan in PFC
  • Altered dopaminergic responses to heptachlor exposure identified

with impairments from, among others:

  • Attention processes
  • Cognitive performance
  • Memory
  • Social development
  • Mental and psychomotor development
  • Fine motor skills
  • Reflexes
  • Visual processing

Organochlorine compounds were nevertheless primarily associated with ASA.

1.1.8.2. Organophosphate contact during pregnancy

The organophosphates chlorpyrifos and diazinon showed significant effects on neonatal brain development, including the dopaminergic system.69 Prenatal exposure to the common pesticide chlorpyrifos impaired IQ and working memory in children aged 77071 and executive functions.72

Organophosphates inhibit acetylcholinesterase (= the enzyme that breaks down acetylcholine).68 The organophosphate diisopropyl fluorophosphate (DFP) has been reported to increase dopamine and GABA receptors in addition to the known downregulation of cholinergic receptors. A single administration of 1 mg/kg DFP caused increased dopamine levels, and a single toxic dose of 2 mg/kg DFP caused increased dopamine depletion. Levels returned to normal after 6 hours. Chronic administration of 1 mg/kg DFP caused decreased dopamine levels after 1 and 2 weeks, which returned to normal with continued administration. A single administration of DFP increased dopamine turnover in the striatum of rats, whereas chronic administration decreased it. The authors suggested that the changes in dopamine and GABA may be consequences of downregulation of cholinergic receptors.73

Chlorpyrifos interferes with the serotonin system. Contact during pregnancy may cause tremor in children and impair cognitive and neurobehavioral development.36

A measurement using prenatal urinary dialkyl phosphate metabolites (diethyl phosphate and dimethyl phosphate) and an analysis of maternal PON1 gene variants Q192R and L55M found no association between maternal organophosphate contact during pregnancy and subsequent ADHD in the child.74

1.1.8.3. Pyrethroid contact before or during pregnancy

Pyrethroids are widely used as insecticides and pesticides.

Each doubling of the pyrethroid metabolite 3-phenoxybenzoic acid (3-PBA) in the mother’s urine at 28 weeks’ gestation increased the risk of ADHD in the offspring by 3% and the risk that an onset of ADHD was among the 10% most severe ADHD cases by 13%.75

The pyrethroid deltamethrin apparently impairs the dopaminergic system in mice when exposed early:76

  • DAT reduced
  • D1 receptor decreased
  • Apoptosis

Further, permanent behavioral changes resulted (with prenatal but not with postnatal exposure)77 in terms of:76

  • Movement activity
  • Acoustic startle reflex
  • Learning
  • Memory

3-PBA and chlorpyrifos enhance each other’s effect on ADHD.75

Each urinary measurement of trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (trans-DCCA), a metabolite of permethrin, cypermethrin, and cyfluthri (trans-isomers of pyrethroids), increased the risk of offspring ADHD by 76%.75

1.1.9. Bisphenols in pregnancy

Bisphenol-A (BPA) is a glucocorticoid receptor agonist and has been associated with alterations in HPA axis response. In female rats, prenatal BPA correlated with increased basal corticosterone levels as well as decreased glucocorticoid receptor expression in the hypothalamus. To stress, these female rats showed anxious coping behavior and a muted corticosterone response with a lack of downregulation of glucocorticoid receptor expression in the hypothalamus. In contrast, BPA-exposed male rats showed no altered basal HPA axis function but failed to upregulate CRH-1 receptor expression in the pituitary in response to acute stress.36 The dose given to rat mothers during pregnancy and suckling was very low at 40 micrograms/kg/day.78
5 milligrams / cubic meter in the breath cause eye irritation.79 A review confirmed circumstantial evidence that bishenol-A during pregnancy may increase the risk of ADHD in children, especially boys,80

BPA and BPS caused greatly increased dopamine (3- to 5-fold) and greatly decreased serotonin (by 80%) in mouse placentas. GABA remained unchanged.81 BPA is an endocrine disruptor and mimics estrogenic activity. Thus, BPA affects various dopaminergic processes to increase mesolimbic dopamine activity, resulting in hyperactivity, attention deficits, and increased susceptibility to drug abuse.82

1.1.10. Phthalates in pregnancy

Phthalic acid esters are said to increase the risk of ADHD for the unborn according to most studies,83 although the correlations are unclear so far.8480 An influence on thyroid balance is discussed.85 Higher phthalate metabolites in the urine of pregnant women correlated with increased distractibility in preschool-aged children.86

1.1.11. Perfluoroalkyl compounds (PFAS) in pregnancy

Polychlorinated biphenyls / polychlorinated biphenyl ethers (up to + 23 %)

A long-term study found no correlation between perflouralkyl exposure during pregnancy and ADHD. Weak correlations - positive and negative - were found with working memory functions in childhood.87 A metastudy also found no significant correlation between maternal PFAS exposure and prevalence rates of early childhood ADHD. Nevertheless, the odds ratios were partially increased:88

  • Perfluorooctanoic acid (PFOA): 1.00
  • Perfluorooctane sulfonate (PFOS): 1.01
  • Perfluorohexane sulfonate (PFHxS): 1.08
  • Perfluorononanoic acid (PFNA): 1.13
  • Perfluorodecanoic acid (PFDA): 1.23

PFOS concentration in children’s blood and PFNA concentration in mothers’ blood correlated with the prevalence of early childhood ADHD.

Polychlorinated biphenyls inhibit dopamine synthesis as well as the storage of dopamine in the vesicles and its release, thus causing a too low dopamine level. Polychlorinated biphenyls induced hyperactivity and impulsivity (in rats even at subtoxic doses).89 Polychlorinated biphenyls may act directly on dopaminergic processes to disrupt the dopamine system and produce Parkinson-like symptoms.82 Other studies also found dopamine-reducing effects of PFAs.9091 as well as influences on acetylcholine, serotonin and glutamate neurotransmitter balance.92

1.1.12. Polycyclic aromatic hydrocarbons (PAH, PAH) (+ 99 to 157 %)

Prenatal exposure to polycyclic aromatic hydrocarbons appears to increase damage from early childhood stress exposure and promote later attention and memory problems.93 One meta-study found that 4 studies by one author indicated a 1.57-fold increase in the risk of ADHD from PAHs (OR 2.57), while the total number of all studies indicated a doubled risk (OR 1.99), but this was not significant.94 Another study also showed an association between PAH and ADHD.95

1.1.13. Air pollution during pregnancy

One study found changes related to the immune system of offspring due to air pollution.96
A study of approximately 43,000 families in Shenzen found positive correlations of ADHD beginning at age 3 with exposure during pregnancy to97

  • Cooking fumes
  • Tobacco smoke
  • Steaming from house renovations
  • Mosquito coils (burnt mosquito pyramids; especially in combination with incense smoke)
  • Incense smoke (especially in combination with mosquito repellent smoke)

Another study found no increase in risk from air pollution in relation to ADHD.98

A meta-analysis found that more studies (not pregnancy-related) affirmed an association between air pollution and ADHD than denied it.99

1.1.13.1. Fine dust

A cohort study of 425,736 births on prenatal particulate matter exposure using satellite data found that a 10 μg/m3 increase in PM2.5 concentration during the first trimester increased ADHD risk by 26% and that this increased further at PM2.5 concentrations above 16 μg/m3.100
Air pollution from particulate matter during pregnancy correlated with decreased corpus callosum volume and a tendency toward increased hyperactivity in one study.101 Another study found a correlation between particulate matter and ADHD at low levels of particulate matter exposure, while higher exposure caused more severe brain damage.95

In rats, inhaled printer particles resulted in 5-fold elevations in dopamine levels, although these likely resulted from increased synthesis rather than decreased degradation.102

Diesel exhaust particles caused functional impairment of dopamine neurons in laboratory experiments. Prenatal ingestion with the respiratory air caused in mice:103

  • In the striatum
    • Reduced dopamine turnover
    • Decreased levels of dopamine metabolites
  • In the amygdala
    • Increased dopamine level
    • Elevated dopamine metabolite levels
  • In the nucleus accumbens
    • Increased dopamine levels

Traffic ultrafine particulate matter in postnatal breath induced in female mice:103

  • In the hippocampus
    • Increased dopamine turnover

Prenatally and postnatally, particulate matter and gaseous pollutants in rodents decreased expression of oxytocin receptors in the hippocampus104 and hypothalamus, with decreased maternal caregiving behavior.105 Oxytocin and vasopressin communication appear to be disrupted by endocrine-disrupting chemicals106, many of which are present in outdoor air.103

1.1.13.2. Nitrogen oxides

A correlation to ASD in children was found for nitric oxide in pregnancy, but not for ADHD.107

1.1.13.3. Ozone

Ozone caused in rats:103

  • In the substantia nigra
    • Reduced number of dopamine neurons
  • In the hippocampus
    • Decreased expression of the serotonin receptors 5-HT1A, 5-HT1B and 5-HT4
    • Increased expression of the serotonin receptor 5-HT2C
  • In the hypothalamus
    • Decreased serotonin levels

1.1.14. Insatiable nausea (hyperemesis gravidarum)

Insatiable maternal emesis and vomiting during pregnancy increased offspring ASD(H)S risk by 16% (in 2 cohort studies) to 287%.108

1.1.15. Dioxin exposure during pregnancy

Children exposed to dioxin during pregnancy have an increased risk of ADHD.109

1.2. Medication of the mother during pregnancy as ADHD risk

Children with ADHD were more likely to have mothers who took medication during pregnancy:2

Medication taken by the mother during pregnancy:

  • ADHD: 43.5 %
    If stress/emotional problems occurred, they were in the following trimester
    • 1st/2nd trimester only: 36.2 %
    • 3rd trimester only: 14.5 %
    • Total pregnancy: 49.3
  • Non-affected: 31.4
    If stress/emotional problems occurred, they were in the following trimester
    • 1st/2nd trimester only: 31.1 %
    • 3rd trimester only: 46.9%
    • Total pregnancy: 21.9

The following list is only exemplary and by no means complete.

1.2.1. Cortisol in pregnancy

Cortisol administration during pregnancy causes long-term changes in the brain of the unborn and increases the risk of ADHD.110 The children suffer a lifelong alteration of the dopaminergic system and the HPA axis, apparently caused by changes in the expression and ratio of MR and GR receptors.111 We believe that the ADHD symptoms described in these children could possibly be the result of HPA axis alteration.
Corticosteroid receptor hypothesis of depression

High fetal or neonatal cortisol exposure may cause methylation of the GAD1 / GAD67 gene, which encodes the key glutamate-to-GABA-synthesizing glutamate decarboxylase 1 enzyme, leading to increased glutamate levels. This epigenetic mechanism may increase ADHD risk in children.112

Exposure to betamethasone during pregnancy only marginally increased the ADHD risk of the offspring.113

1.2.2. β-2-Adrenaline receptor agonists in pregnancy (+30%)

Taking β-2-adrenergic receptor agonists during pregnancy increases the risk of ADHD for the child by up to 30%.114

1.2.3. Paracetamol (acetaminophen) in pregnancy (+ 37 to 250%)

Taking paracetamol (in North America and Iran: acetaminophen) during pregnancy increased the risk of ADHD by up to 37%. Even short-term use is harmful according to two very comprehensive studies with a combined total of over 110,000 participants.115116117118 Critically, Gilman et al. While the previous studies were based on mothers’ intake reports, a study based on blood levels found a 2.3 to 3.5-fold ADHD risk and a 1.6 to 4.1-fold ASA risk in children when taken in the second or third trimester of pregnancy.119120

The ADHD risk from paracetamol (acetaminophen) increases when it is taken121

  • In the second trimester of pregnancy by 19%
  • By 28 % in the first and second trimester
  • In the first to third trimester by 20%

A cohort study of 116,000 children showed that fever in the first trimester of pregnancy increased ADHD risk by 31%, and multiple fevers by 164%. However, fever only increased inattention, not hyperactivity/impulsivity - this was also true for the second trimester. The results were independent of whether the mother was taking acetaminophen (paracetamol) or not.122

One study challenges the previous critical findings by focusing on parent ADHD diagnoses not previously considered.123 Also doubting Damkier.124

A long-term study analyzed paracetamol, methionine, serine, glycine, and glutamate in umbilical cord plasma and found an increasing risk of ADHD with elevated paracetamol levels paralleling the increase in 8-hydroxy-deoxyguanosine levels in umbilical cord blood. Increases in cord blood levels of methionine, glycine, serine, and 8-hydroxy-deoxyguanosine correlated with a significantly higher likelihood of ADHD in infancy. Methionine and glycine mediated 22% each of the association between elevated paracetamol levels and later ADHD.125

Ibuprofen, on the other hand, is not thought to pose an ADHD risk to the unborn child.

1.2.4. Benzodiazepines in pregnancy

Benzodiazepines in pregnancy appear to increase the risk of internalizing problems in children (anxiety, emotional reactivity, somatic complaints) but not externalizing problems (hyperactivity, aggressiveness).126

1.2.5. SSRIs, antidepressants in pregnancy

SSRIs in pregnancy correlate with significantly increased infant mental disorders, according to a meta-analysis of 18 studies. It is not clear whether this results from the SSRIs or from the mother’s existing mental health problems for which she was treated with SSRIs.127 Purely as a precaution, SSRIs should be used with extreme caution during pregnancy.
One metastudy found no increased risk of ADHD in children in 7 of 8 studies of SSRIs during pregnancy.128 According to one study, antidepressants during pregnancy increased the likelihood of later ADHD in the child by 1.81-fold.129

1.2.6. Valproic acid in pregnancy

Offspring of mice that received valproic acid during pregnancy showed markedly increased hyperactivity and changes in the dentate gyrus.130131

1.2.7. Valproate in pregnancy (+ 12 %)

Valproate in pregnancy is thought to increase the risk of ADHD to the unborn child.132
Valproates are the salts of valproic acid.

When antiepileptic drugs were taken during pregnancy, a cohort study found an increased risk of neurodevelopmental disorders in children up to 6 years of age (which is too early to diagnose all ADHD sufferers):

  • Sodium valproate together with other antipsychotics: 15%
  • Sodium valproate as monotherapy: 12%
  • Lamotrigine 6.3% (not a statistically significant increase due to the small number of participants in this group)
  • Carbamazepine 2% (no significant increase)
  • Children not exposed to any of these drugs during pregnancy: 1.8%

Autistic spectrum disorder was the most common diagnosis. 2% of children of medicated mothers received an ADHD diagnosis by age 6 years, 1.5% dyspraxia. Among controls, no child had an ADHD diagnosis.133

1.2.8. Antibiotics in pregnancy (+ 14 %)

One metastudy found a 14% increased ADHD risk from maternal antibiotic use during pregnancy.134

1.2.9. No increase in risk from NSAIDs, normal caffeine consumption

A cohort study found no ADHD risk increase with nonsteroidal anti-inflammatory drugs (NSAIDs) in pregnancy.135

Caffeine consumption during pregnancy below 10 cups per day did not increase ADHD risk.136

This list of maternal medications in pregnancy as ADHD risk is only exemplary and by no means complete.

1.3. Psychological stress of the mother during pregnancy

Maternal stress during pregnancy doubled the risk of ADHD in the children.137
Prolonged and severe (fearful, perceived threatening = cortisol tolerant) stress significantly increases the risk for crying children138 (see also 2.2.2.3.2), anxiety disorders and ADHD.139140141142
In this context, prolonged stress (here: financial problems) is more harmful than short-term stress (here: loss of a close person).143
High anxiety/threat perceived stress at the same time significantly increases the risk for borderline in children.

Children with ADHD were more likely to have mothers who experienced stress or emotional problems during pregnancy:2

  • Children with ADHD: 53.8 %
    If stress/emotional problems occurred, they were in the following trimester
    • 1st/2nd trimester only: 36.0%
    • 3rd trimester only: 6.7 %
    • Total pregnancy: 57.3
  • Non-affected children: 27.6 %
    If stress/emotional problems occurred, they were in the following trimester
    • 1st/2nd trimester only: 28.6 %
    • 3rd trimester only: 24.9 %
    • Total pregnancy: 28.6

Hair cortisol levels of mothers and their children showed a transmission of psychological stress experiences from mothers to children.144
One study found no increased psychiatric disorders at age 9 in children of women exposed to one month of repeated rocket fire on civilians during the 2006 Lebanon War.145 It is possible that one month of repeated stress is not a sufficiently intense stressor.

The mother’s cortisol, which is released during fearful/threatening stress, is absorbed by the unborn and causes permanent damage to the HPA axis, which uses cortisol to regulate stress responses.146147

Severe maternal anxiety in pregnancy during weeks 12 to 22 after the last menstrual period significantly increases the risk for ADHD, whereas severe anxiety during weeks 32 to 40 does not increase the risk.148

Severe maternal anxiety during pregnancy increased the ADHD risk of the unborn child depending on its COMT gene variant (gene-environment interaction).149
In mothers with the ADGRL3 (latrophilin 3, LPHN3) gene variants (SNPs)

  • rs6551665
  • rs1947274
  • rs6858066 or
  • rs2345039

even low stress during pregnancy caused a significantly increased ADHD risk for the child.150

Early prenatal stress increases levels of immune response genes, including the proinflammatory cytokines IL-6 and IL-1β, particularly in male placentas. Male infants exhibit stress-induced locomotor hyperactivity, a hallmark of dopaminergic dysregulation that was ameliorated by maternal treatment with nonsteroidal anti-inflammatory drugs. In addition, expression of dopamine D1 and D2 receptors was altered by early prenatal stress in male offspring.151 The actuates the effect of early stress on the dopaminergic system.

High cortisol exposure of the fetus or newborn may cause methylation of the GAD1 / GAD67 gene, which encodes the key enzyme for glutamate-to-GABA synthesis, glutamate decarboxylase 1, and lead to elevated glutamate levels. This epigenetic mechanism may increase ADHD risk in children.112 Exposure to glucocorticoids during hippocampal development in pregnancy affects the starting point of the stress response through epigenetic changes via mRNA and methylation.152 Another study reported that the increase in risk to the unborn for developmental disorders such as ADHD mediated by maternal psychological stress may be mediated by mRNA expression of glucocorticoid pathway genes in the placenta.153
Another study also describes epigenetic changes in the unborn due to psychological stress of the mother during pregnancy.154
Another study found no significant increase in risk for mental disorders by 10 years of age from increased glucocorticoid exposure in the unborn.155

In primates, the stress hormone cortisol is converted to its inactive form by the enzyme hydroxysteroid 11-β-dehydrogenase 2 (HSD11B2). This conversion in the placenta also protects the fetus.156157 However, chronic maternal stress (as well as malnutrition or hypoxia) decreases HSD11B2 expression in the placenta.157 Fetuses of chrinically stressed mothers are therefore exposed to high cortisol concentrations, triggering developmental delays and neurodevelopmental disorders such as ADHD.158159157 In rodents, expression of Hsd11b1, which encodes an enzyme regulating the activity of stress-related hormones in the neocortex, is instead reduced.160

1.4. Severe maternal obesity before or during pregnancy (+14 to 280%)

Massive maternal obesity during pregnancy increased the risk of later ADHD in the child by 2.8 times in one study.161
Already an excessive BMI of the mother before pregnancy increased the ADHD risk of the later offspring.162 A BMI of 25-30 increased the ADHD risk of the child by 14%, a BMI of 30-35 by 96% and a BMI of more than 35 by 82%.163
Other variations in maternal weight before and at the end of pregnancy do not appear to affect ADHD risk.5

1.5. Pre-eclampsia (gestosis) in pregnancy (+ 30 to 188 %)

Problems in pregnancy that affect the oxygen supply to the fetus increase the risk of ADHD in the child by 30% to 188%.164 One cohort study found a 43% ADHD risk increase from gestational gestosis.165 Several review studies confirm an increased ADHD risk from preeclampsia in pregnancy.166167

Preeclampsia is related to alterations in the adenosine system including adenosine transporters and adenosine receptors. SHR are born in a preeclampsia-like situation due to maternal hypertension. Caffeine (an adenosine antagonist) in 7-day-old SHR prevented the negative consequences of preeclampsia (hyperactivity, worsened social interaction, worsened contextual fear conditioning), whereas it exacerbated these symptoms in Wistar rats.168
Hypoxia (lack of oxygen) increases adenosine. Adenosine antagonists can prevent or resolve the adverse effects of hypoxia. For more on this topic, see ⇒ Adenosine In the chapter Neurological Aspects.

High levels of the (weak) adenosine antagonist theobromine correlated negatively with preeclampsia.169

1.6. Mineral and vitamin deficiency during pregnancy

A meta-study found evidence that higher levels of omega-3 fatty acids in the newborn may reduce the risk and severity of ADHD and autism spectrum disorders. It is possible that an adequate supply of omega-3 fatty acid in the last trimester of pregnancy could counteract this.170

Vitamin D3 deficiency during pregnancy and after birth causes maldevelopments of the brain,171172 173 which, however, correlate more with schizophrenia.
A large long-term study in Spain of vitamin D3 deficiency in pregnancy found no correlation between low maternal blood D3 levels in pregnancy and ADHD in children aged 5 to 18 years.174
A study in Finland, on the other hand, found a clear correlation between reduced maternal D3 levels during pregnancy and ADHD in children. The risk increase reached up to more than 50 %.175
We assume that the difference results from the fact that the sunlight intensity in Spain is high enough almost all year round to form D3, whereas in Germany, and even more so in more northern countries, the sunlight intensity during the winter months is too low to mediate D3 formation .

More on this at Vitamins, minerals, dietary supplements in ADHD As well as Nutrition and diet in ADHD in the chapter Treatment and therapy.

1.7. Unhealthy diet of the mother during pregnancy (+ 60 %)

Unhealthy or a “Western” dietary intake by the mother during pregnancy increased the children’s likelihood of ADHD by more than 60%.176
Since stress increases the preference for “convienient foods,” we believe that the correlation could possibly also be an indirect reflection of increased maternal stress during pregnancy, since stress alters food preferences toward more rapidly digestible foods and convienient foods

1.8. Maternal fever during pregnancy (+31 to 164%)

A cohort study of 114,000 children showed that fever in the first trimester of pregnancy increased ADHD risk by 31%, and multiple fevers by 164%. However, fever only increased inattention, not hyperactivity/impulsivity - this was also true for the second trimester. The results were independent of whether the mother was taking acetaminophen (paracetamol) or not.122

1.9. Anemia (anemia) of the mother during pregnancy (+ 31 %)

A cohort study of 532,232 children over 23 years of age showed that maternal anemia in the first 30 weeks of pregnancy increased ADHD risk by 31%, whereas anemia in later weeks of pregnancy barely increased risk (by 1.4%) 177

1.10. Parents’ asthma in and out of pregnancy (+ 13 to 41%)

A cohort study of 961,202 children showed a 41% increased risk of ADHD with maternal asthma and a 13% increased risk with paternal asthma. A maternal asthma episode during pregnancy increased ADHD risk by 21%, and a post-pregnancy asthma episode by 25%.178 Another study also found an increased ADHD risk in the offspring of mothers with asthma, especially for girls.179

1.11. Diabetes of one parent (+ 40 %)

Maternal diabetes before or during pregnancy increases the offspring’s risk for ADHD and ASD.180
A cohort study of more than 5 million people found an increased risk of ADHD in children if a parent had diabetes.181
Diabetes mellitus or type 1 diabetes mellitus of the mother before pregnancy increased the ADHD risk of the children by 40%, type 1 diabetes mellitus of the father by 20%.
Another study found a 2.4-fold ADHD risk in children of mothers with diabetes mellitus and a 3.7-fold ADHD risk in male offspring of mothers with diabetes mellitus. No differences were found between gestational diabetes and diabetes elsewhere.182
Children of non-insulin-treated severely obese mothers with type 2 diabetes were 2 times more likely to show psychiatric disorders than offspring of normal-weight mothers. Children of insulin-treated severely obese mothers with pregestational diabetes were 2.7 times more likely to show psychiatric disorders than offspring of normal-weight mothers.183

1.12. Depression of the mother during pregnancy

Particularly in boys, the severity of maternal depression during pregnancy and higher maternal cyclothymic, irritable, and anxious temperament scores appear to be relevant risk factors for the development of ADHD.184

1.13. Elevated thyroxine levels in the mother

Reduced or untreated normal thyroxine levels showed the mother no influence on ADHD of the children. In contrast, thyroxine treatment of the mother, especially with excessive thyroxine levels due to overdose, appears to increase the children’s risk of ADHD.185 Another study also found evidence of thyroxine as a possible cause of ADHD,186 another study found no influence of maternal thyroxine levels during pregnancy.187

In male mice, one study found significantly reduced dopamine and serotonin turnover in the striatum, nucleus accumbens, hypothalamus, and hippocampus as a result of prenatal thyroxine deficiency.188 Dopamine deficiency in the striatum / nucleus accumbens is responsible for hyperactive symptoms in ADHD.

1.13.1. Decreased and increased neonatal TSH levels (+14% in boys to +310% in girls)

A cohort study from Norway found that neonates with TSH levels that were too low or too high had an increased risk of ADHD later in life, but only in girls. TSH levels in the lowest 20% group increased the ADHD risk of girls 3.1-fold, of boys only 14%.189

1.14. Viral infections of the mother during pregnancy

Viral infection of the mother during pregnancy may affect the development of the dopaminergic system of the unborn child, e.g.:190

  • Measles
  • Varicella
  • Rubella
  • Enterovirus 71
  • Herpes virus 6
  • Influenza A

A connection seems less certain for

  • Streptococcal infection
  • Middle ear infection (otitis media)

1.15. Particularly short or long intervals to the previous pregnancy (+ 25 to 30 %)

Particularly short or a particularly long interval of pregnancy with the preceding sibling increased the risk of ADHD by 30% (less than 6 months) and 12% (60-119 months) to 25% (120 months and more), respectively.191

1.16. Maternal exposure to non-ionizing magnetic field radiation during pregnancy (+100%)

Children whose mothers were most exposed to non-ionizing magnetic field radiation (“electrosmog”) during pregnancy (at a 24-hour measurement),192

  • Showed a doubled risk for ADHD (aHR 2.01)
  • Persistence of ADHD beyond age 11 was more than three times more likely to correlate with high maternal exposure than remission of ADHD by age 11 (aHR 3.38).
  • ADHD with comorbid immune-related comorbidities (asthma or neurodermatitis/atopic dermatitis) was 4.57 times more likely to be correlated with high exposure.
  • A coincidence of ADHD persisting beyond age 11 and immune-related comorbidities was 8.27 times more likely to be associated with exposure.

1.17. Polycystic ovary syndrome (PCOS) in pregnancy (+95% in boys)

Children of women with polycystic ovary syndrome (PCOS) appear to be at increased risk for ADHD.193

It is possible that a link could arise from the fact that one method of treatment is the use of dopamine agonists.194195

One study found a 95% increased risk of ADHD in 3-year-old boys of mothers with PCOS, whereas this was not increased in 3-year-old girls.196

1.18. Hypertension during pregnancy

High blood pressure during pregnancy significantly increases the ADHD risk of the offspring.167
Hypertension is associated with genetically inherited ADHD risks. Therefore, it will be necessary to differentiate whether hypertension during pregnancy causally increases ADHD risk or whether elevated blood pressure during pregnancy is an expression of the underlying genetic burden that mediates ADHD.

1.19. Decreased C-reactive protein (CRP) (+ 92 %)

Children of mothers whose CRP levels were in the lowest third of the subject group had nearly double the risk of ASD and ADHD compared with children of mothers from the middle third in CRP.197

1.20. Systemic lupus erythematosus (SLE) (+ 60 %)

Children of mothers who had systemic lupus erythematosus (SLE) were found to have a 60% increased risk of ADHD.198

1.21. Less than 8 hours of sleep in the 3rd trimester of pregnancy

Girls of mothers with less than 8 hours of sleep in the last trimester of pregnancy were more likely to show hyperactivity, inattention, and ADHD total scores.199

1.22. Pregnancy circumstances without influence on ADHD

1
A large study of 3 cohorts found no effect of maternal urinary iodine/creatinine ratio during pregnancy on the child’s risk of ADHD or ASD.200
One metastudy found no evidence of increased ADHD risk from maternal migration, but it was different for ASA.201


  1. Manzari, Matvienko-Sikar, Baldoni, O’Keeffe, Khashan (2019): Prenatal maternal stress and risk of neurodevelopmental disorders in the offspring: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2019 Jul 20. doi: 10.1007/s00127-019-01745-3. REVIEW

  2. Lipińska, Słopień, Pytlińska, Słopień, Wolańczyk, Bryńska (2021): The role of factors associated with the course of pregnancy and childbirth in attention deficit hyperactivity disorder (ADHD). Psychiatr Pol. 2021 Jun 30;55(3):659-673. English, Polish. doi: 10.12740/PP/OnlineFirst/110686. PMID: 34460889. n = 311

  3. http://www.adhs.org/genese/

  4. Banerjee TD, Middleton F, Faraone SV: Environmental risk factors for attention-deficit hyperactivity disorder. Acta Pædiatrica 2007;96, 1269–74. Zitiert nach Philipsen, Heßlinger, Tebartz van Elst: AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313

  5. Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0.

  6. Wang, Hu, Chen, Xue, Du (2019): Prenatal Tobacco Exposure Modulated the Association of Genetic variants with Diagnosed ADHD and its symptom domain in children: A Community Based Case-Control Study. Sci Rep. 2019 Mar 12;9(1):4274. doi: 10.1038/s41598-019-40850-w.

  7. Zambrano-Sánchez, Martínez-Cortés, Poblano, Dehesa-Moreno, Vázquez-Urbano, Del Río-Carlos (2019): Maternal smoking during pregnancy and physiological anxiety in children with attention deficit hyperactivity disorder. Appl Neuropsychol Child. 2019 Jul 3:1-8. doi: 10.1080/21622965.2019.1632708.

  8. McCarthy, Zhang, Wilkes, Vaillancourt, Biederman, Bhide (2022): Nicotine and the developing brain: Insights from preclinical models. Pharmacol Biochem Behav. 2022 Feb 14:173355. doi: 10.1016/j.pbb.2022.173355. PMID: 35176350.

  9. Deng, Yang, Wang, Zhou, Wang, Zhang, Niu (2022): Identification and Characterization of Influential Factors in Susceptibility to Attention Deficit Hyperactivity Disorder Among Preschool-Aged Children. Front Neurosci. 2022 Jan 31;15:709374. doi: 10.3389/fnins.2021.709374. PMID: 35173570; PMCID: PMC8841729. n = 7.938

  10. Rice, Langley, Woodford, Smith, Thapar (2018): Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy. Dev Psychopathol. 2018 Aug;30(3):1107-1128. doi: 10.1017/S0954579418000421.

  11. Thapar, Rice (2020): Family-Based Designs that Disentangle Inherited Factors from Pre- and Postnatal Environmental Exposures: In Vitro Fertilization, Discordant Sibling Pairs, Maternal versus Paternal Comparisons, and Adoption Designs. Cold Spring Harb Perspect Med. 2020 Mar 9:a038877. doi: 10.1101/cshperspect.a038877.. PMID: 32152247.

  12. Haan, Westmoreland, Schellhas, Sallis, Taylor, Zuccolo, Munafò (2022): Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta-analysis. Addiction. 2022 Apr 6. doi: 10.1111/add.15858. PMID: 35385887.

  13. Polli, Kohlmeier (2019): Prenatal nicotine exposure in rodents: why are there so many variations in behavioral outcomes? Nicotine Tob Res. 2019 Oct 9. pii: ntz196. doi: 10.1093/ntr/ntz196.

  14. Neuman, Lobos, Reich, Henderson, Sun, Todd (2007): Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007 Jun 15;61(12):1320-8.

  15. Dryden (2007): Prenatal smoking increases ADHD risk in some children. Erläuterung zu Neuman et al.

  16. Sánchez-Mora, Richarte, Garcia-Martínez, Pagerols, Corrales, Bosch, Vidal, Viladevall, Casas, Cormand, Ramos-Quiroga, Ribasés (2015): Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340.

  17. Minatoya, Araki, Itoh, Yamazaki, Kobayashi, Miyashita, Sasaki, Kishi (2019): Prenatal tobacco exposure and ADHD symptoms at pre-school age: the Hokkaido Study on Environment and Children’s Health. Environ Health Prev Med. 2019 Dec 7;24(1):74. doi: 10.1186/s12199-019-0834-4.

  18. Polli, Kohlmeier (2019): Alterations in NMDAR-mediated signaling within the laterodorsal tegmental nucleus are associated with prenatal nicotine exposure. Neuropharmacology. 2019 Aug 19;158:107744. doi: 10.1016/j.neuropharm.2019.107744.

  19. Polli, Ipsen, Caballero-Puntiverio, Østerbøg, Aznar, Andreasen, Kohlmeier (2020): Cellular and Molecular Changes in Hippocampal Glutamate Signaling and Alterations in Learning, Attention, and Impulsivity Following Prenatal Nicotine Exposure. Mol Neurobiol. 2020 Jan 8. doi: 10.1007/s12035-019-01854-9.

  20. Buck, O’Neill, Stitzel (2019): Developmental nicotine exposure elicits multigenerational disequilibria in proBDNF proteolysis and glucocorticoid signaling in the frontal cortices, striata, and hippocampi of adolescent mice. Biochem Pharmacol. 2019 Aug 9;168:438-451. doi: 10.1016/j.bcp.2019.08.003.

  21. Alkam, Mamiya, Kimura, Yoshida, Kihara, Tsunoda, Aoyama, Hiramatsu, Kim, Nabeshima (2017): Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice. Psychopharmacology (Berl). 2017 Jun;234(12):1853-1869. doi: 10.1007/s00213-017-4591-z.

  22. Buck, O’Neill, Stitzel (2020): Developmental nicotine exposure engenders intergenerational downregulation and aberrant posttranslational modification of cardinal epigenetic factors in the frontal cortices, striata, and hippocampi of adolescent mice. Epigenetics Chromatin. 2020 Mar 5;13(1):13. doi: 10.1186/s13072-020-00332-0. PMID: 32138755; PMCID: PMC7059320.

  23. Mahlberg, James, Bulten, Rodriguez, Kwan, Cairney (2019): Investigating the Association Between Exposure to Second Hand Smoke in utero and Developmental Coordination Disorder. Front Pediatr. 2019 Nov 5;7:438. doi: 10.3389/fped.2019.00438. eCollection 2019.

  24. Yohn, Caruso, Blendy (2019): Effects of nicotine and stress exposure across generations in C57BL/6 mice, Stress, 22:1, 142-150, DOI: 10.1080/10253890.2018.1532991

  25. McCarthy, Morgan, Lowe, Williamson, Spencer, Biederman, Bhide (2018): Nicotine exposure of male mice produces behavioral impairment in multiple generations of descendants. PLoS Biol 16(10): e2006497. https://doi.org/10.1371/journal.pbio.2006497

  26. Buck, Sanders, Wageman, Knopik, Stitzel, O’Neill (2019): Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice. Neuropharmacology. 2019 May 1;149:66-82. doi: 10.1016/j.neuropharm.2019.02.006. PMID: 30742847; PMCID: PMC7096676.

  27. Zhang M, Zhang D, Dai J, Cao Y, Xu W, He G, Wang Z, Wang L, Li R, Qiao Z. Paternal nicotine exposure induces hyperactivity in next-generation via down-regulating the expression of DAT. Toxicology. 2020 Feb 15;431:152367. doi: 10.1016/j.tox.2020.152367. Epub 2020 Jan 13. PMID: 31945395.

  28. van Mil, Steegers-Theunissen, Bouwland-Both, Verbiest, Rijlaarsdam, Hofman, Steegers, Heijmans, Jaddoe, Verhulst, Stolk, Eilers, Uitterlinden, Tiemeier (2014): DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res. 2014 Feb;49:51-9. doi: 10.1016/j.jpsychires.2013.10.017. PMID: 24290898.

  29. Nygaard, Slinning, Moe, Fjell, Walhovd (2019): Mental health in youth prenatally exposed to opioids and poly-drugs and raised in permanent foster/adoptive homes: A prospective longitudinal study. Early Hum Dev. 2019 Oct 29;140:104910. doi: 10.1016/j.earlhumdev.2019.104910.

  30. Roncero, Valriberas-Herrero, Mezzatesta-Gava, Villegas, Aguilar, Grau-López (2020): Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health. 2020 Feb 17;17(1):25. doi: 10.1186/s12978-020-0880-9. PMID: 32066469; PMCID: PMC7027300. REVIEW

  31. Pagnin, Zamboni Grecco, Furtado (2018): Prenatal alcohol use as a risk for attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2018 Oct 23. doi: 10.1007/s00406-018-0946-7. n = 81

  32. van de Bor (2019): Fetal toxicology. Handb Clin Neurol. 2019;162:31-55. doi: 10.1016/B978-0-444-64029-1.00002-3.

  33. Wang, Martin, Lei, Hausknecht, Ishiwari, Richards, Haj-Dahmane, Shen (2020): Prenatal Ethanol Exposure Leads to Attention Deficits in Both Male and Female Rats. Front Neurosci. 2020 Jan 24;14:12. doi: 10.3389/fnins.2020.00012. PMID: 32038156; PMCID: PMC6992663.

  34. Haan, Sallis, Ystrom, Njølstad, Andreassen, Reichborn-Kjennerud, Munafò, Havdahl, Zuccolo (2021): Maternal and offspring genetic risk score analyses of fetal alcohol exposure and attention-deficit hyperactivity disorder risk in offspring. Alcohol Clin Exp Res. 2021 Sep 6. doi: 10.1111/acer.14692. PMID: 34486127.

  35. Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0. n = 573

  36. Cowell, Wright (2017): Sex-Specific Effects of Combined Exposure to Chemical and Non-chemical Stressors on Neuroendocrine Development: a Review of Recent Findings and Putative Mechanisms. Current environmental health reports, 4(4), 415-425. REVIEW

  37. San Martin Porter, Maravilla, Betts, Alati (2019): Low-moderate prenatal alcohol exposure and offspring attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis. Arch Gynecol Obstet. 2019 Aug;300(2):269-277. doi: 10.1007/s00404-019-05204-x. REVIEW

  38. Kjaer Weile, Wu, Hegaard, Kesmodel, Henriksen, Nohr (2019: Alcohol intake in early pregnancy and risk of Attention-Deficit Hyperactivity Disorder (ADHD) in children up to 19 years of age: a cohort study. Alcohol Clin Exp Res. 2019 Nov 19. doi: 10.1111/acer.14243. n = 48.072

  39. Reilhac, Garlantézec, Lacroix, Rouget, Warembourg, Monfort, Le Gléau, Cordier, Viel, Chevrier (2019): Prenatal exposure to glycol ethers and response inhibition in 6-year-old children: The PELAGIE cohort study. Environ Res. 2019 Nov 21:108950. doi: 10.1016/j.envres.2019.108950.

  40. Fransquet, Hutchinson, Olsson, Wilson, Allsop, Najman, Elliott, Mattick, Saffery, Ryan (2016): Triple B Research Consortium. Perinatal maternal alcohol consumption and methylation of the dopamine receptor DRD4 In the offspring: the Triple B study. Environ Epigenet. 2016 Dec 7;2(4):dvw023. doi: 10.1093/eep/dvw023. PMID: 29492300; PMCID: PMC5804537. n = 844

  41. Schneider, Moore, Barnhart, Larson, DeJesus, Mukherjee, Nickles, Converse, Roberts, Kraemer (2005): Moderate-level prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys. Alcohol Clin Exp Res. 2005 Sep;29(9):1685-97. doi: 10.1097/01.alc.0000179409.80370.25. PMID: 16205369.

  42. Lee, Park, Ryu, Shin, Ko, Han, Koren, Cho (2015): Changes in the methylation status of DAT, SERT, and MeCP2 gene promoters in the blood cell in families exposed to alcohol during the periconceptional period. Alcohol Clin Exp Res. 2015 Feb;39(2):239-50. doi: 10.1111/acer.12635. PMID: 25656446.

  43. Shabanov, Lebedev, Bychkov (2012): [The effect of ethanol exposure in pregnancy on maturation of monoaminergic systems in the developing rat bran]. Ross Fiziol Zh Im I M Sechenova. 2012 Feb;98(2):202-11. Russian. PMID: 22650063.

  44. Schneider, Moore, Barr, Larson, Kraemer (2011): Moderate prenatal alcohol exposure and serotonin genotype interact to alter CNS serotonin function in rhesus monkey offspring. Alcohol Clin Exp Res. 2011 May;35(5):912-20. doi: 10.1111/j.1530-0277.2010.01421.x. PMID: 21294753; PMCID: PMC3083456.

  45. De Nicolò, Carito, Fiore, Laviola (2014): Aberrant behavioral and neurobiologic profiles in rodents exposed to ethanol or red wine early in development. Curr. Dev. Disord. Rep. 2014;1:173–180. doi: 10.1007/s40474-014-0023-5.

  46. Kazemi, Huang, Avci, Akay, Akay (2021): Investigating the effects of chronic perinatal alcohol and combined nicotine and alcohol exposure on dopaminergic and non-dopaminergic neurons in the VTA. Sci Rep. 2021 Apr 22;11(1):8706. doi: 10.1038/s41598-021-88221-8. PMID: 33888815; PMCID: PMC8062589.

  47. Dingess, Thakar, Zhang, Flynn, Brown (2018): High-Salt Exposure During Perinatal Development Enhances Stress Sensitivity. Dev Neurobiol. 2018 Nov;78(11):1131-1145. doi: 10.1002/dneu.22635.

  48. Peters, Frühgeborene und Schule – Ermutigt oder ausgebremst? Kapitel 2: Das Aufmerksamkeitsdefizitsyndrom (AD(H)S), Seite 126

  49. http://www.adhs.org/genese/ mit weiteren Nachweisen

  50. van de Bor (2019): Fetal toxicology. Handb Clin Neurol. 2019;162:31-55. doi: 10.1016/B978-0-444-64029-1.00002-3.

  51. RÍsovÁ (2020): The pathway of lead through the mother’s body to the child. Interdiscip Toxicol. 2019 Sep;12(1):1-6. doi: 10.2478/intox-2019-0001. PMID: 32189981; PMCID: PMC7061448. REVIEW

  52. Cory-Slechta, Virgolini, Thiruchelvam, Weston, Bauter (2004): Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect. 2004 May;112(6):717-30.

  53. Cory-Slechta, Stern, Weston, Allen, Liu (2010): Enhanced learning deficits in female rats following lifetime pb exposure combined with prenatal stress. Toxicol Sci. 2010 Oct;117(2):427-38. doi: 10.1093/toxsci/kfq221.

  54. Virgolini, Rossi-George, Lisek, Weston, Thiruchelvam, Cory-Slechta (2008): CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress. Neurotoxicology. 2008 Sep;29(5):812-27. doi: 10.1016/j.neuro.2008.03.003.

  55. Weston, Weston, Allen, Cory-Slechta (2014): Sex-dependent impacts of low-level lead exposure and prenatal stress on impulsive choice behavior and associated biochemical and neurochemical manifestations. Neurotoxicology. 2014 Sep;44:169-83. doi: 10.1016/j.neuro.2014.06.013.

  56. Austin, Curtin, Curtin, Gennings, Arora, Tammimies, Isaksson, Willfors, Bölte (2019): Dynamical properties of elemental metabolism distinguish attention deficit hyperactivity disorder from autism spectrum disorder. Transl Psychiatry. 2019 Sep 25;9(1):238. doi: 10.1038/s41398-019-0567-6.

  57. Markovac, Goldstein (1988): Picomolar concentrations of lead stimulate brain protein kinase C. Nature volume 334, pages 71–3, 1988

  58. Arnsten (2009): Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009 Jun;10(6):410-22. doi: 10.1038/nrn2648.

  59. Gedeon, Ramesh, Wellman, Jadhav (2001): Changes in mesocorticolimbic dopamine and D1/D2 receptor levels after low level lead exposure: a time course study, Toxicology Letters, Volume 123, Issues 2–3, 2001, Pages 217-226, ISSN 0378-4274, https://doi.org/10.1016/S0378-4274(01)00408-8

  60. Morgan, Garavan, Smith, Driscoll, Levitsky, Strupp (2001): Early lead exposure produces lasting changes in sustained attention, response initiation, and reactivity to errors, Neurotoxicology and Teratology, Volume 23, Issue 6, 2001, Pages 519-531, ISSN 0892-0362, https://doi.org/10.1016/S0892-0362(01)00171-4.

  61. Lidsky, Schneider (2003): Lead neurotoxicity in children: basic mechanisms and clinical correlates, Brain, Volume 126, Issue 1, January 2003, Pages 5–19, https://doi.org/10.1093/brain/awg014

  62. Cecil, Brubaker, Adler, Dietrich, Altaye, Egelhoff, Wessel, Elangovan, Hornung, Jarvis, Lanphear (2008) Decreased Brain Volume in Adults with Childhood Lead Exposure. PLoS Med 5(5): e112. https://doi.org/10.1371/journal.pmed.0050112.

  63. Nevin (2000): How Lead Exposure Relates to Temporal Changes in IQ, Violent Crime, and Unwed Pregnancy, Environmental Research, Volume 83, Issue 1, 2000, Pages 1-22, ISSN 0013-9351, https://doi.org/10.1006/enrs.1999.4045.

  64. Wright, Dietrich, Ris, Hornung, Wessel, Lanphear, Ho, Rae (2008): Association of Prenatal and Childhood Blood Lead Concentrations with Criminal Arrests in Early Adulthood. PLoS Med 5(5): e101. https://doi.org/10.1371/journal.pmed.0050101

  65. Xi, Wu (2021): A Review on the Mechanism Between Different Factors and the Occurrence of Autism and ADHD. Psychol Res Behav Manag. 2021 Apr 9;14:393-403. doi: 10.2147/PRBM.S304450. PMID: 33859505; PMCID: PMC8044340. REVIEW

  66. Kim, Jang, Lim, Kim, Shin, Lee, Kim, Hong (2020): The Effect of Prenatal Cadmium Exposure on Attention-deficit/Hyperactivity Disorder in 6-Year-old Children in Korea. J Prev Med Public Health. 2020 Jan;53(1):29-36. doi: 10.3961/jpmph.19.175. PMID: 32023672; PMCID: PMC7002990.

  67. Tong, Liang, Huang, Xiang, Qi, Feng, Lai, Shao, Wu, Tao (2020): Prenatal serum thallium exposure and 36-month-old children’s attention-deficit/hyperactivity disorder symptoms: Ma’anshan birth cohort study. Chemosphere. 2020 Apr;244:125499. doi: 10.1016/j.chemosphere.2019.125499. PMID: 32050328.

  68. Vester, Caudle (2016): The Synapse as a Central Target for Neurodevelopmental Susceptibility to Pesticides. Toxics. 2016 Aug 26;4(3):18. doi: 10.3390/toxics4030018. PMID: 29051423; PMCID: PMC5606656. REVIEW

  69. Slotkin, Seidler (2007): Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems. Brain Res Bull. 2007 May 30;72(4-6):232-74. doi: 10.1016/j.brainresbull.2007.01.005. PMID: 17452286; PMCID: PMC1945108.

  70. Rauh, Arunajadai, Horton, Perera, Hoepner, Barr, Whyatt (2011): Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect. 2011 Aug;119(8):1196-201. doi: 10.1289/ehp.1003160. PMID: 21507777; PMCID: PMC3237355.

  71. Bouchard, Chevrier, Harley, Kogut, Vedar, Calderon, Trujillo, Johnson, Bradman, Barr, Eskenazi (2011): Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect. 2011 Aug;119(8):1189-95. doi: 10.1289/ehp.1003185. PMID: 21507776; PMCID: PMC3237357.

  72. [Thistle, Ramos, Roell, Choi, Manley, Hall, Villanger, Cequier, Sakhi, Thomsen, Zeiner, Reichborn-Kjennerud, Øvergaard, Herring, Aase, Engel (2022): Prenatal organophosphorus pesticide exposure and executive function in preschool-aged children in the Norwegian Mother, Father and Child Cohort Study (MoBa). Environ Res. 2022 May 22:113555. doi: 10.1016/j.envres.2022.113555. PMID: 35613628.)](https://pubmed.ncbi.nlm.nih.gov/35613628/

  73. Ho, Hoskins (1990): Dopamine in organophosphate-induced neurotoxicity. J Toxicol Sci . 1990 Dec;15 Suppl 4:159-61. doi: 10.2131/jts.15.supplementiv_159. REVIEW

  74. Manley, Villanger, Thomsen, Cequier, Sakhi, Reichborn-Kjennerud, Herring, Øvergaard, Zeiner, Roell, Engel, Kamai, Thistle, Hall, Aase, Engel (2022): Prenatal Exposure to Organophosphorus Pesticides and Preschool ADHD in the Norwegian Mother, Father and Child Cohort Study. Int J Environ Res Public Health. 2022 Jul 2;19(13):8148. doi: 10.3390/ijerph19138148. PMID: 35805806.

  75. Dalsager, Fage-Larsen, Bilenberg, Jensen, Nielsen, Kyhl, Grandjean, Andersen (2019): Maternal urinary concentrations of pyrethroid and chlorpyrifos metabolites and attention deficit hyperactivity disorder (ADHD) symptoms in 2-4-year-old children from the Odense Child Cohort. Environ Res. 2019 Sep;176:108533. doi: 10.1016/j.envres.2019.108533.

  76. Pitzer, Williams, Vorhees (2021) Effects of pyrethroids on brain development and behavior: Deltamethrin. Neurotoxicol Teratol. 2021 Apr 20;87:106983. doi: 10.1016/j.ntt.2021.106983. PMID: 33848594. REVIEW

  77. Xi, Yang, Yu, Li, He, El-Aziz, Zhao, Cao (2022): Influence of perinatal deltamethrin exposure at distinct developmental stages on motor activity, learning and memory. Ecotoxicol Environ Saf. 2022 Apr 1;236:113460. doi: 10.1016/j.ecoenv.2022.113460. PMID: 35378399.

  78. Panagiotidou, Zerva, Mitsiou, Alexis, Kitraki (2014): Perinatal exposure to low-dose bisphenol A affects the neuroendocrine stress response in rats. J Endocrinol. 2014 Jan 27;220(3):207-18. doi: 10.1530/JOE-13-0416.

  79. Gestis-Stoffdatenbank zu Bisphenol

  80. Minatoya, Kishi (2021): A Review of Recent Studies on Bisphenol A and Phthalate Exposures and Child Neurodevelopment. Int J Environ Res Public Health. 2021 Mar 30;18(7):3585. doi: 10.3390/ijerph18073585. PMID: 33808331. REVIEW

  81. Mao, Jain, Denslow, Nouri, Chen, Wang, Zhu, Koh, Sarma, Sumner, Lei, Sumner, Bivens, Roberts, Tuteja, Rosenfeld (2020): Bisphenol A and bisphenol S disruptions of the mouse placenta and potential effects on the placenta-brain axis. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4642-4652. doi: 10.1073/pnas.1919563117. Epub 2020 Feb 18. PMID: 32071231; PMCID: PMC7060676.

  82. Jones, Miller (2008): The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochem Pharmacol. 2008 Sep 1;76(5):569-81. doi: 10.1016/j.bcp.2008.05.010. PMID: 18555207. REVIEW

  83. Barrett (2019): Attention Worthy: Prenatal Phthalate Exposure and Subsequent ADHD Diagnosis Science Selection; CID: 034001https://doi.org/10.1289/EHP3815

  84. Radke, Braun, Nachman, Cooper (2020): Phthalate exposure and neurodevelopment: A systematic review and meta-analysis of human epidemiological evidence. Environ Int. 2020 Feb 8;137:105408. doi: 10.1016/j.envint.2019.105408. PMID: 32045779. REVIEW

  85. Salazar, Villaseca, Cisternas, Inestrosa (2021). Neurodevelopmental impact of the offspring by thyroid hormone system-disrupting environmental chemicals during pregnancy. Environ Res. 2021 Jun 1;200:111345. doi: 10.1016/j.envres.2021.111345. PMID: 34087190.

  86. Ku, Tsai, Wang, Su, Sun, Wang, Wang (2019): Prenatal and childhood phthalate exposure and attention deficit hyperactivity disorder traits in child temperament: A 12-year follow-up birth cohort study. Sci Total Environ. 2019 Aug 29;699:134053. doi: 10.1016/j.scitotenv.2019.134053.

  87. Skogheim, Villanger, Weyde, Engel, Surén, Øie, Skogan, Biele, Zeiner, Øvergaard, Haug, Sabaredzovic, Aase (2019): Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children. Int J Hyg Environ Health. 2019 Oct 22. pii: S1438-4639(19)30570-X. doi: 10.1016/j.ijheh.2019.10.003.

  88. Qu, Cao, Li, Wang, Liu, Wang, Nie, Sun, Liu, Zhang (2021): The association between maternal perfluoroalkyl substances exposure and early attention deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2021 Jul 9. doi: 10.1007/s11356-021-15136-2. PMID: 34244930.

  89. Chishti, Fisher, Seegal (1996): Aroclors 1254 and 1260 reduce dopamine concentrations in rat striatal slices. Neurotoxicology. 1996 Fall-Winter;17(3-4):653-60.

  90. Grønnestad, Schlenk, Krøkje, Jaspers, Jenssen, Coffin, Bertotto, Giroux, Lyche, Arukwe (2021): Alteration of neuro-dopamine and steroid hormone homeostasis in wild Bank voles in relation to tissue concentrations of PFAS at a Nordic skiing area. Sci Total Environ. 2021 Feb 20;756:143745. doi: 10.1016/j.scitotenv.2020.143745. PMID: 33250251.

  91. [Sammi, Foguth, Nieves, De Perre, Wipf, McMurray, Lee, Cannon (2019): Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans. Toxicol Sci. 2019 Dec 1;172(2):417-434. doi: 10.1093/toxsci/kfz191. PMID: 31428778; PMCID: PMC6876260.)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876260/

  92. Foguth, Hoskins, Clark, Nelson, Flynn, de Perre, Hoverman, Lee, Sepúlveda, Cannon (2020): Single and mixture per- and polyfluoroalkyl substances accumulate in developing Northern leopard frog brains and produce complex neurotransmission alterations. Neurotoxicol Teratol. 2020 Sep-Oct;81:106907. doi: 10.1016/j.ntt.2020.106907. PMID: 32561179.

  93. Pagliaccio, Herbstman, Perera, Tang, Goldsmith, Peterson, Rauh, Margolis (2020): Prenatal exposure to polycyclic aromatic hydrocarbons modifies the effects of early life stress on attention and Thought Problems in late childhood. J Child Psychol Psychiatry. 2020 Jan 7. doi: 10.1111/jcpp.13189.

  94. Rezaei Kalantary, Jaffarzadeh, Rezapour, Hesami Arani (2020): Association between exposure to polycyclic aromatic hydrocarbons and attention deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2020 Apr;27(11):11531-11540. doi: 10.1007/s11356-020-08134-3. PMID: 32124297. n = 2.799, 6 Studien, REVIEW

  95. Peterson, Bansal, Sawardekar, Nati, Elgabalawy, Hoepner, Garcia, Hao, Margolis, Perera, Rauh (2022): Prenatal exposure to air pollution is associated with altered brain structure, function, and metabolism in childhood. J Child Psychol Psychiatry. 2022 Feb 14. doi: 10.1111/jcpp.13578. PMID: 35165899.

  96. Cowell, Wright (2017): Sex-Specific Effects of Combined Exposure to Chemical and Non-chemical Stressors on Neuroendocrine Development: a Review of Recent Findings and Putative Mechanisms. Current environmental health reports, 4(4), 415-425.

  97. Fang, Strodl, Liu, Liu, Yin, Wen, Sun, Xian, Jiang, Jing, Jin, Wu, Chen (2019): Association between prenatal exposure to household inhalants exposure and ADHD-like behaviors at around 3 years of age: Findings from Shenzhen Longhua Child Cohort Study. Environ Res. 2019 Jul 26;177:108612. doi: 10.1016/j.envres.2019.108612.

  98. Forns, Sunyer, Garcia-Esteban, Porta, Ghassabian, Giorgis-Allemand, Gong, Gehring, Sørensen, Standl, Sugiri, Almqvist, Andiarena, Badaloní, Beelen, Berdel, Cesaroni, Charles, Eriksen, Estarlich, Fernandez, Forhan, Jaddoe, Korek, Lichtenstein, Lertxundi, Lopez-Espinosa, Markevych, de Nazelle, Raaschou-Nielsen, Nieuwenhuijsen, Pérez-Lobato, Philippat, Slama, Tiesler, Verhulst, von Berg, Vrijkotte, Nybo Andersen, Heude, Krämer, Heinrich, Tiemeier, Forastiere, Pershagen, Brunekreef, Guxens (2018): Air pollution exposure during pregnancy and symptoms of attention deficit and hyperactivity disorder in children in Europe. Epidemiology. 2018 Jun 19. doi: 10.1097/EDE.0000000000000874.; n = 29127

  99. Aghaei, Janjani, Yousefian, Jamal, Yunesian (2019): Association between ambient gaseous and particulate air pollutants and attention deficit hyperactivity disorder (ADHD) in children; a systematic review. Environ Res. 2019 Mar 15;173:135-156. doi: 10.1016/j.envres.2019.03.030. REVIEW

  100. Chang YC, Chen WT, Su SH, Jung CR, Hwang BF (2022): PM2.5 exposure and incident attention-deficit/hyperactivity disorder during the prenatal and postnatal periods: A birth cohort study. Environ Res. 2022 Jun 28:113769. doi: 10.1016/j.envres.2022.113769. PMID: 35777438. n = 425.736

  101. Mortamais, Pujol, Martínez-Vilavella, Fenoll, Reynes, Sabatier, Rivas, Forns, Vilor-Tejedor, Alemany, Cirach, Alvarez-Pedrerol, Nieuwenhuijsen, Sunyer (2019): Effects of prenatal exposure to particulate matter air pollution on corpus callosum and behavioral problems in children. Environ Res. 2019 Nov;178:108734. doi: 10.1016/j.envres.2019.108734.

  102. Carll, Salatini, Pirela, Wang, Xie, Lorkiewicz, Naeem, Qian, Castranova, Godleski, Demokritou (2020): Inhalation of printer-emitted particles impairs cardiac conduction, hemodynamics, and autonomic regulation and induces arrhythmia and electrical remodeling in rats. Part Fibre Toxicol. 2020 Jan 29;17(1):7. doi: 10.1186/s12989-019-0335-z. PMID: 31996220; PMCID: PMC6990551.

  103. Weitekamp, Hofmann (2021): Effects of air pollution exposure on social behavior: a synthesis and call for research. Environ Health. 2021 Jun 25;20(1):72. doi: 10.1186/s12940-021-00761-8. PMID: 34187479; PMCID: PMC8243425. REVIEW

  104. Emam, Shahsavani, Khodagholi, Zarandi, Hopke, Hadei, Behbahani, Yarahmadi (2020): Effects of PM2.5 and gases exposure during prenatal and early-life on autism-like phenotypes in male rat offspring. Part Fibre Toxicol. 2020 Jan 29;17(1):8. doi: 10.1186/s12989-020-0336-y. PMID: 31996222; PMCID: PMC6990481.

  105. Win-Shwe, Fujitani, Kyi-Tha-Thu, Furuyama, Michikawa, Tsukahara, Nitta, Hirano (2014): Effects of diesel engine exhaust origin secondary organic aerosols on novel object recognition ability and maternal behavior in BALB/c mice. Int J Environ Res Public Health. 2014 Oct 30;11(11):11286-307. doi: 10.3390/ijerph111111286. PMID: 25361045; PMCID: PMC4245613.

  106. Patisaul (2017): Endocrine Disruption of Vasopressin Systems and Related Behaviors. Front Endocrinol (Lausanne). 2017 Jun 19;8:134. doi: 10.3389/fendo.2017.00134. PMID: 28674520; PMCID: PMC5475378.

  107. Oudin, Frondelius, Haglund, Källén, Forsberg, Gustafsson, Malmqvist (2019): Prenatal exposure to air pollution as a potential risk factor for autism and ADHD. Environ Int. 2019 Oct 16;133(Pt A):105149. doi: 10.1016/j.envint.2019.105149.

  108. Nijsten, Jansen, Limpens, Finken, Koot, Grooten, Roseboom, Painter (2022): Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022 Mar 30:S0002-9378(22)00249-6. doi: 10.1016/j.ajog.2022.03.052. PMID: 35367190.

  109. Pham-The T, Nishijo M, Pham TN, Vu HT, Tran NN, Tran AH, Hoang LV, Do Q, Nishino Y, Nishijo H. (2022): Perinatal Dioxin Exposure and Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Children Living in a Dioxin Contamination Hotspot in Vietnam. Toxics. 2022 Apr 24;10(5):212. doi: 10.3390/toxics10050212. PMID: 35622626; PMCID: PMC9143824.

  110. Khalife, Glover, Taanila, Ebeling, Järvelin, Rodriguez (2013): Prenatal Glucocorticoid Treatment and Later Mental Health in Children and Adolescents; Plos one, November 22, 2013; https://doi.org/10.1371/journal.pone.0081394, n = 222

  111. Kapoor, Petropoulos, Matthews (2007): Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev. 2008 Mar;57(2):586-95.

  112. Shaw, Crombie, Zakar, Palliser, Hirst (2019): Perinatal compromise contributes to programming of GABAergic and glutamatergic systems leading to long-term effects on offspring behaviour. J Neuroendocrinol. 2019 Nov 23:e12814. doi: 10.1111/jne.12814.

  113. Rakers, Schleußner, Muth, Hoyer, Rupprecht, Schiecke, Groten, Dreiling, Kozik, Schwab, Hoyer, Ligges (2022): Association between antenatal glucocorticoid exposure and the activity of the stress system, cognition, and behavior in 8- to 9-year-old children: A prospective observational study. Acta Obstet Gynecol Scand. 2022 Jun 2. doi: 10.1111/aogs.14386. PMID: 35652410. n = 69

  114. Liang, Chen, Miao, Christensen, Dalsgaard, Yuan, Li (2017): In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children. Eur Child Adolesc Psychiatry. 2017 Feb 9. doi: 10.1007/s00787-017-0956-4 n = 672.000!!!

  115. Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013 Dec;42(6):1702-13. doi: 10.1093/ije/dyt183. PubMed PMID: 24163279; PubMed Central PMCID: PMC3887567. n = 48.631

  116. Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders. JAMA Pediatr. 2014 Feb 24. doi: 10.1001/jamapediatrics.2013.4914. PubMed PMID:24566677. n = 64.322

  117. Liew, Kioumourtzoglou, Roberts, O’Reilly, Ascherio, Weisskopf (2019): Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses’ Health Study II. Am J Epidemiol. 2019 Apr 1;188(4):768-775. doi: 10.1093/aje/kwy288.

  118. Masarwa, Levine, Gorelik, Reif, Perlman, Matok (2019): Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies. Am J Epidemiol. 2018 Aug 1;187(8):1817-1827. doi: 10.1093/aje/kwy086. REVIEW

  119. Gilman, Hornig (2019): The Disillusionment of DOHaD Epidemiology. Am J Epidemiol. 2019 Oct 2. pii: kwz214. doi: 10.1093/aje/kwz214.

  120. Ji, Azuine, Zhang, Hou, Hong, Wang, Riley, Pearson, Zuckerman, Wang (2019): Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorderand Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2019 Oct 30:1-11. doi: 10.1001/jamapsychiatry.2019.3259.

  121. Chen, Pan, Wang, Hsu, Huang, Su, Li, Lin, Tsai, Chen, Bai (2019): Prenatal Exposure to Acetaminophen and the Risk of Attention-Deficit/Hyperactivity Disorder: A Nationwide Study in Taiwan. J Clin Psychiatry. 2019 Sep 10;80(5). pii: 18m12612. doi: 10.4088/JCP.18m12612. n = 950 Mutter-Kind-Paare

  122. Gustavson, Ask, Ystrom, Stoltenberg, Lipkin, Surén, Håberg, Magnus, Knudsen, Eilertsen, Bresnahan, Aase, Mjaaland, Susser, Hornig, Reichborn-Kjennerud (2019): Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder. Sci Rep. 2019 Jul 2;9(1):9519. doi: 10.1038/s41598-019-45920-7.

  123. Masarwa, Platt, Filion (2020): Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias? Paediatr Perinat Epidemiol. 2020 Jan 9. doi: 10.1111/ppe.12615.

  124. Damkier (2020): Simple twist of fate: In utero exposure to acetaminophen and risk of childhood Attention Deficit Hyperactivity Disorder. Paediatr Perinat Epidemiol. 2020 May;34(3):230-232. doi: 10.1111/ppe.12654. PMID: 32107788.

  125. Anand, Raghavan, Wang, Hong, Azuine, Pearson, Zuckerman, Xie, Wang (2021): Perinatal Acetaminophen Exposure and Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Exploring the Role of Umbilical Cord Plasma Metabolites in Oxidative Stress Pathways. Brain Sci. 2021 Sep 30;11(10):1302. doi: 10.3390/brainsci11101302. PMID: 34679367; PMCID: PMC8533963. N = 568

  126. Brandlistuen, Eivind Ystrom, Hernandez-Diaz, Skurtveit, Selmer, Handal, Nordeng, Sasayama (2017): Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study; PLoS One. 2017; 12(7): e0181042. doi: 10.1371/journal.pone.0181042; PMCID: PMC5528839; n = 71.996

  127. Halvorsen, Hesel, Østergaard, Danielsen (2019): In Utero Exposure to SSRIs and Development of Mental Disorders: A Systematic Review and Meta-analysis. Acta Psychiatr Scand. 2019 Apr 2. doi: 10.1111/acps.13030. REVIEW

  128. Araujo, Delgado, Paumgartten (2020): Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review. Cad Saude Publica. 2020 Jan 31;36(2):e00026619. doi: 10.1590/0102-311X00026619. PMID: 32022173. REVIEW

  129. Clements, Castro, Blumenthal, Rosenfield, Murphy, Fava, Erb, Churchill, Kaimal, Doyle, Robinson, Smoller, Kohane, Perlis (2015): Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry volume 20, pages 727–734 (2015) n = 3620

  130. Kinjo, Ito, Seki, Fukuhara, Bolati, Arai, Suzuki (2019): Prenatal exposure to valproic acid is associated with altered neurocognitive function and neurogenesis in the dentate gyrus of male offspring rats. Brain Res. 2019 Aug 22;1723:146403. doi: 10.1016/j.brainres.2019.146403.

  131. Sakade, Yamanaka, Soumiya, Furukawa, Fukumitsu (2019): Exposure to valproic acid during middle to late-stage corticogenesis induces learning and social behavioral abnormalities with attention deficit/hyperactivity in adult mice. Biomed Res. 2019;40(5):179-188. doi: 10.2220/biomedres.40.179.

  132. Baldwin, Amaro (2019): Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? CNS Drugs. 2019 Dec 16. doi: 10.1007/s40263-019-00694-4.

  133. Imhoff-Hasse (2013): Valproatexposition des Fetus I: Risiko für autistische Störungen ist erhöht, Dtsch Arztebl 2013; 110(9): A-386 / B-352 / C-352 unter Verweis auf Bromley, Mawer, Briggs, Cheyne, Clayton-Smith, García-Fiñana, Kneen, Lucas, Shallcross, Baker, Liverpool and Manchester Neurodevelopment Group (2013): The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637-43. doi: 10.1136/jnnp-2012-304270.

  134. Ai, Zhao, Shi, Zhu (2021): Antibiotic exposure and childhood attention-deficit/hyperactivity disorder: systematic review and meta-analysis. Psychopharmacology (Berl). 2021 Oct 23. doi: 10.1007/s00213-021-05989-3. PMID: 34687335.

  135. Hjorth, Lupattelli, Handal, Spigset, Ystrom, Nordeng (2021): Prenatal Exposure to Non-Steroidal Anti-Inflammatory Drugs and Risk of Attention-Deficit/Hyperactivity Disorder – a Follow-Up Study in the Norwegian Mother, Father and Child Cohort. Pharmacoepidemiol Drug Saf. 2021 Apr 18. doi: 10.1002/pds.5250. PMID: 33866622. n = 56 340 / 34 961

  136. Cortés-Albornoz, García-Guáqueta, Velez-van-Meerbeke, Talero-Gutiérrez (2021): Maternal Nutrition and Neurodevelopment: A Scoping Review. Nutrients. 2021 Oct 8;13(10):3530. doi: 10.3390/nu13103530. PMID: 34684531; PMCID: PMC8538181. REVIEW

  137. Kacharava, Nemsadze, Inasaridze (2022): PRESENCE OF PRENATAL MATERNAL STRESS INCREASES THE RISK OF THE DEVELOPMENT OF ADHD SYMPTOMS IN YOUNG CHILDREN. Georgian Med News. 2022 Mar;(324):92-101. PMID: 35417868.

  138. Wurmser, Rieger, Domogalla, Kahnt, Buchwald, Kowatsch, Kuehnert, Buske-Kirschbaum, Papousek, Pirke, von Voss (2006): Assiciation between life stress durcing prengnancy and infant crying in the first six months postpartum: A prospective longitudinal study. Early Human Development 82, 341-349

  139. Talge, Neal, Glover (2007): Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):245-61.

  140. von Lüpke: Die ADHS-Problematik hat eine lange Geschichte, Seite 4

  141. [Bolea-Alamañac, Davies, Evans, Joinson, Pearson, Skapinakis, Emond (2019): Does maternal somatic anxiety in pregnancy predispose children to hyperactivity? Eur Child Adolesc Psychiatry. 2019 Mar 13. doi: 10.1007/s00787-019-01289-6.](https://www.ncbi.nlm.nih.gov/pubmed/30868247

  142. Lautarescu, Craig, Glover (2020): Prenatal stress: Effects on fetal and child brain development. Int Rev Neurobiol. 2020;150:17-40. doi: 10.1016/bs.irn.2019.11.002. Epub 2019 Dec 14. PMID: 32204831. REVIEW

  143. Rosenqvist, Sjölander, Ystrom, Larsson, Reichborn-Kjennerud (2018): Adverse family life events during pregnancy and ADHD symptoms in five-year-old offspring. J Child Psychol Psychiatry. 2018 Oct 27. doi: 10.1111/jcpp.12990. n = 34.751

  144. Agapaki, Papagianni, Metallinou, Valavani, Mantzou, Kanelli, Eleftheriades, Spyropoulou, Zervas, Chrousos, Pervanidou (2022): Associations between Maternal and Offspring Hair Cortisol Concentrations and Child Behavioral Symptoms in Mother-Child Pairs with Perinatal Mental Disorders. Children (Basel). 2022 May 31;9(6):810. doi: 10.3390/children9060810. PMID: 35740747; PMCID: PMC9221619.

  145. Barzilay, Lawrence, Berliner, Gur, Leventer-Roberts, Weizman, Feldman (2019): Association between prenatal exposure to a 1-month period of repeated rocket attacks and neuropsychiatric outcomes up through age 9: a retrospective cohort study. Eur Child Adolesc Psychiatry. 2019 Nov 4. doi: 10.1007/s00787-019-01426-1. n = 14.053

  146. Grizenko, Shayan, Polotskaia, Ter-Stepanian, Joober (2008): Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD; J Psychiatry Neurosci. 2008 Jan; 33(1): 10–16. PMCID: PMC2186370

  147. Glover (2015): Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv Neurobiol. 2015;10:269-83. doi: 10.1007/978-1-4939-1372-5_13.

  148. Van den Bergh, B. R.H. and Marcoen, A. (2004), High Antenatal Maternal Anxiety Is Related to ADHD Symptoms, Externalizing Problems, and Anxiety in 8- and 9-Year-Olds. Child Development, 75: 1085–1097. doi:10.1111/j.1467-8624.2004.00727.x

  149. O’Donnell, Glover, Lahti, Lahti, Edgar, Räikkönen, O’Connor (2017): Maternal prenatal anxiety and child COMT genotype predict working memory and symptoms of ADHD. PLoS One. 2017 Jun 14;12(6):e0177506. doi: 10.1371/journal.pone.0177506. eCollection 2017.

  150. Choudhry, Sengupta, Grizenko, Fortier, Thakur, Bellingham, Joober (2012): LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J Child Psychol Psychiatry. 2012 Aug;53(8):892-902. doi: 10.1111/j.1469-7610.2012.02551.x. PMID: 22486528.

  151. Bronson, Bale (2014): Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology. 2014 Jul;155(7):2635-46. doi: 10.1210/en.2014-1040.

  152. Provençal, Arloth, Cattaneo, Anacker, Cattane, Wiechmann, Röh, Ködel, Klengel, Czamara, Müller, Lahti; PREDO team, Räikkönen, Pariante, Binder (2019): Glucocorticoid exposure during hippocampal neurogenesis primes future stress response by inducing changes in DNA methylation. Proc Natl Acad Sci U S A. 2019 Aug 9. pii: 201820842. doi: 10.1073/pnas.1820842116.

  153. Finik, Buthmann, Zhang, Go, Nomura (2020): Placental Gene Expression and Offspring Temperament Trajectories: Predicting Negative Affect in Early Childhood. J Abnorm Child Psychol. 2020 Jun;48(6):783-795. doi: 10.1007/s10802-020-00632-9. PMID: 32185610; PMCID: PMC7242121.

  154. Stonawski, Frey, Golub, Moll, Heinrich, Eichler (2018): [Epigenetic modifications in children associated with maternal emotional stress during pregnancy]. [Article in German] Z Kinder Jugendpsychiatr Psychother. 2018 Mar;46(2):155-167. doi: 10.1024/1422-4917/a000515.

  155. Suarez, Lahti, Lahti-Pulkkinen, Girchenko, Czamara, Arloth, Malmberg, Hämäläinen, Kajantie, Laivuori, Villa, Reynolds, Provençal, Binder, Räikkönen (2020): A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders. Neurobiol Stress. 2020 Nov 21;13:100275. doi: 10.1016/j.ynstr.2020.100275. PMID: 33344728; PMCID: PMC7739178. n = 814 Kinder / childs von / of n = 408 Müttern / mothers

  156. Dy, Guan, Sampath-Kumar, Richardson, Yang (2008): Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta. 2008 Feb;29(2):193-200. doi: 10.1016/j.placenta.2007.10.010. PMID: 18061258.

  157. Zhu, Wang, Zuo, Sun (2019): Mechanisms for establishment of the placental glucocorticoid barrier, a guard for life. Cell Mol Life Sci. 2019 Jan;76(1):13-26. doi: 10.1007/s00018-018-2918-5. PMID: 30225585. REVIEW

  158. Doi, Usui, Shimada (2022): Prenatal Environment and Neurodevelopmental Disorders. Front Endocrinol (Lausanne). 2022 Mar 15;13:860110. doi: 10.3389/fendo.2022.860110. PMID: 35370942; PMCID: PMC8964779., REVIEW

  159. Babenko, Kovalchuk, Metz (2015): Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev. 2015 Jan;48:70-91. doi: 10.1016/j.neubiorev.2014.11.013. PMID: 25464029. REVIEW

  160. Doi, Oka, Taniguchi, Sato (2021): Transient expansion of the expression region of Hsd11b1, encoding 11β-hydroxysteroid dehydrogenase type 1, in the developing mouse neocortex. J Neurochem. 2021 Nov;159(4):778-788. doi: 10.1111/jnc.15505. PMID: 34490902.

  161. Buss, Entringer, Davis, Hobel, Swanson, Wadhwa, Sandman (2012): Impaired Executive Function Mediates the Association between Maternal Pre-Pregnancy Body Mass Index and Child ADHD Symptoms https://doi.org/10.1371/journal.pone.0037758

  162. Jenabi, Bashirian, Khazaei, Basiri (2019): The maternal pre-pregnancy BMI and the risk of ADHD among children and adolescents: A systematic review and meta-Analysis. Korean J Pediatr. 2019 Jun 14. doi: 10.3345/kjp.2019.00185. REVIEW

  163. Robinson, Ghassabian, Sundaram, Trinh, Lin, Bell, Yeung (2020): Parental Weight Status and Offspring Behavioral Problems and Psychiatric Symptoms. J Pediatr. 2020 May;220:227-236.e1. doi: 10.1016/j.jpeds.2020.01.016. PMID: 32067780; PMCID: PMC7186145.

  164. Getahun, Rhoads, Demissie, Lu, Quinn, Fassett, Wing. Jacobsen (2013): In utero exposure to ischemic-hypoxic conditions and attention-deficit/hyperactivity disorder. Pediatrics 131 1 (2013): e53-61.

  165. Maher, Dalman, O’Keeffe, Kearney, McCarthy, Kenny, Khashan (2020): Association between preeclampsia and attention-deficit hyperactivity disorder: a population-based and sibling-matched cohort study. Acta Psychiatr Scand. 2020 Feb 13. doi: 10.1111/acps.13162. PMID: 32056200. n = 2.047.619

  166. Gumusoglu, Chilukuri, Santillan, Santillan, Stevens (2020): Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure. Trends Neurosci. 2020 Apr;43(4):253-268. doi: 10.1016/j.tins.2020.02.003. PMID: 32209456; PMCID: PMC7170230. REVIEW

  167. Zhao J, Xia L.(2022): Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis. Hypertens Pregnancy. 2022 May 28:1-10. doi: 10.1080/10641955.2022.2079674. PMID: 35634947. REVIEW

  168. Ramos, de Mattos Hungria, Camerini, Suiama, Calzavara (2020): Potential beneficial effects of caffeine administration in the neonatal period of an animal model of schizophrenia. Behav Brain Res. 2020 Aug 5;391:112674. doi: 10.1016/j.bbr.2020.112674. PMID: 32417274.

  169. Triche, Grosso, Belanger, Darefsky, Benowitz, Bracken (2008): Chocolate consumption in pregnancy and reduced likelihood of preeclampsia. Epidemiology. 2008 May;19(3):459-64. doi: 10.1097/EDE.0b013e31816a1d17. PMID: 18379424; PMCID: PMC2782959.

  170. Martins, Bandarra, Figueiredo-Braga (2019): The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder – a review. Crit Rev Food Sci Nutr. 2019 Mar 18:1-16. doi: 10.1080/10408398.2019.1573800. REVIEW

  171. Kesby, Cui, Ko, McGrath, Burne, Eyles (2009): Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain, Neuroscience Letters, Volume 461, Issue 2, 2009, Pages 155-158, ISSN 0304-3940, https://doi.org/10.1016/j.neulet.2009.05.070

  172. Eyles, Feron, Cui, Kesby, Harms, Ko, McGrath, Burne (2009): Developmental vitamin D deficiency causes abnormal brain development, Psychoneuroendocrinology, Volume 34, Supplement 1, 2009, Pages S247-S257, ISSN 0306-4530, https://doi.org/10.1016/j.psyneuen.2009.04.015.

  173. Almeras, Eyles, Benech, Laffite, Villard, Patatian, Boucraut, Mackay‐Sim, McGrath, Féron (2007): Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics, 7: 769-780. https://doi.org/10.1002/pmic.200600392

  174. López-Vicente, Sunyer, Lertxundi, González, Rodríguez-Dehli, Espada Sáenz-Torre, Vrijheid, Tardón, Llop, Torrent, Ibarluzea, Guxens (2019): Maternal circulating Vitamin D3 levels during pregnancy and behaviour across childhood. Sci Rep. 2019 Oct 15;9(1):14792. doi: 10.1038/s41598-019-51325-3.

  175. Sucksdorff, Brown, Chudal, Surcel, Hinkka-Yli-Salomäki, Cheslack-Postava, Gyllenberg, Sourander (2019): Maternal Vitamin D Levels and the Risk of Offspring Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019 Dec 18. pii: S0890-8567(19)32232-4. doi: 10.1016/j.jaac.2019.11.021. n = 2.124

  176. Galera, Heude, Forhan, Bernard, Peyre, Van der Waerden, Pryor, Bouvard, Melchior, Lioret, de Lauzon-Guillain (2018): EDEN Mother-Child Cohort Study Group. Prenatal diet and children’s trajectories of hyperactivity-inattention and conduct problems from 3 to 8 years: the EDEN mother-child cohort. J Child Psychol Psychiatry. 2018 Sep;59(9):1003-1011. doi: 10.1111/jcpp.12898. PMID: 29573342. n = 1.242 Mutter-Kind-Paare / mother-child pairs

  177. Wiegersma, Dalman, Lee, Karlsson, Gardner (2019): Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders. JAMA Psychiatry. 2019 Sep 18:1-12. doi: 10.1001/jamapsychiatry.2019.2309.

  178. Liu, Dalsgaard, Olsen, Li, Wright, Momen (2019): Parental asthma occurrence, exacerbations and risk of attention-deficit/hyperactivity disorder. Brain Behav Immun. 2019 Aug 30. pii: S0889-1591(19)30738-X. doi: 10.1016/j.bbi.2019.08.198. n = 961.202

  179. Cowell, Bellinger, Wright, Wright (2019): Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children. Brain Behav Immun. 2019 Aug;80:871-878. doi: 10.1016/j.bbi.2019.05.040.

  180. Ornoy, Becker, Weinstein-Fudim, Ergaz (2021): Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring. A Clinical Review. Int J Mol Sci. 2021 Mar 15;22(6):2965. doi: 10.3390/ijms22062965. PMID: 33803995. REVIEW

  181. Zeng, Tang, Yue, Li, Qiu, Hu, Tang, Wang, Yang, Qu, Mu (2019): Cumulative evidence for association of parental diabetes mellitus and attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2019 Nov 7. pii: S0149-7634(19)30721-3. doi: 10.1016/j.neubiorev.2019.11.003.

  182. Lin, Lin, Chou, Lee, Hong (2019): Infants of Mothers With Diabetes and Subsequent Attention Deficit Hyperactivity Disorder: A Retrospective Cohort Study. Front Pediatr. 2019 Nov 4;7:452. doi: 10.3389/fped.2019.00452. eCollection 2019.

  183. Kong, Nilsson, Brismar, Gissler, Lavebratt (2020): Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders. JAMA Netw Open. 2020 Feb 5;3(2):e1920787. doi: 10.1001/jamanetworkopen.2019.20787. PMID: 32031649. n = 649.043

  184. Şair, Sevinçok, Kutlu, Çakaloz, Sevinçok (2019): The affective temperament traits and pregnancy-related depression in mothers may constitute risk factors for their children with attention deficit and hyperactivity disorder. J Obstet Gynaecol. 2019 Dec 8:1-6. doi: 10.1080/01443615.2019.1679741.

  185. Hales, Taylor, Channon, McEwan, Thapar, Langley, Muller, Draman, Dayan, Gregory, Okosieme, Lazarus, Rees, Ludgate (2019): Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child behaviour. J Clin Endocrinol Metab. 2019 Oct 29. pii: dgz098. doi: 10.1210/clinem/dgz098.

  186. Demeneix (2019): Evidence for Prenatal Exposure to Thyroid Disruptors and Adverse Effects on Brain Development. Eur Thyroid J. 2019 Dec;8(6):283-292. doi: 10.1159/000504668. PMID: 31934553; PMCID: PMC6944944.

  187. Levie, Korevaar, Mulder, Bath, Dineva, Lopez-Espinosa, Basterrechea, Santa Marina, Rebagliato, Sunyer, Rayman, Tiemeier, Peeters, Guxens (2019): Maternal Thyroid Function in Early Pregnancy and Child Attention-Deficit Hyperactivity Disorder: An Individual-Participant Meta-Analysis. Thyroid. 2019 Aug 20. doi: 10.1089/thy.2018.0794.

  188. Umezu, Kita, Morita (2019): Hyperactive behavioral phenotypes and an altered brain monoaminergic state in male offspring mice with perinatal hypothyroidism. Toxicol Rep. 2019 Oct 7;6:1031-1039. doi: 10.1016/j.toxrep.2019.10.005. eCollection 2019.

  189. Villanger, Ystrom, Engel, Longnecker, Pettersen, Rowe, Reichborn-Kjennerud, Aase (2020): Neonatal thyroid-stimulating hormone and association with attention-deficit/hyperactivity disorder. Paediatr Perinat Epidemiol. 2020 Sep;34(5):590-596. doi: 10.1111/ppe.12643. PMID: 32072662; PMCID: PMC7431377. n = 1.497

  190. Verlaet, Noriega, Hermans, Savelkoul (2014): Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry. 2014 Jul;23(7):519-29. doi: 10.1007/s00787-014-0522-2. PMID: 24493267. REVIEW

  191. Cheslack-Postava, Sourander, Suominen, Jokiranta-Olkoniemi, McKeague, Brown (2020): Increased Risk of ADHD at Short and Long Interpregnancy Intervals in a National Birth Cohort. Paediatr Perinat Epidemiol. 2020 Mar 12. doi: 10.1111/ppe.12657. PMID: 32162359. n = 44.043

  192. Li, Chen, Ferber, Hirst, Odouli (2020): Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort. JAMA Netw Open. 2020 Mar 2;3(3):e201417. doi: 10.1001/jamanetworkopen.2020.1417. PMID: 32207831; PMCID: PMC7093768. n = 1.454 Mutter-Kind Paare

  193. Maleki, Bashirian, Soltanian, Jenabi, Farhadinasab (2021): Association between polycystic ovary syndrome and risk of attention-deficit/hyperactivity disorder in offspring: a meta-analysis. Clin Exp Pediatr. 2021 Apr 15. doi: 10.3345/cep.2021.00178. PMID: 33872487. METASTUDIE

  194. Kasum, Oresković (2010): Treatment of ovarian hyperstimulation syndrome: new insights. Acta Clin Croat. 2010 Dec;49(4):421-7. PMID: 21830453. REVIEW

  195. Bracero, Zacur (2001): Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am. 2001 Mar;28(1):77-84. doi: 10.1016/s0889-8545(05)70186-8. PMID: 11293005. REVIEW

  196. Dalgaard, Andersen, Jensen, Larsen, Find, Boye, Jensen, Bilenberg, Glintborg (2021): Maternal polycystic ovary syndrome and attention deficit hyperactivity disorder in offspring at 3 years of age: Odense Child Cohort. Acta Obstet Gynecol Scand. 2021 Sep 6. doi: 10.1111/aogs.14259. PMID: 34490610. n = 1.776 Mütter

  197. Brynge, Gardner, Sjöqvist, Karlsson, Dalman (2022): Maternal levels of acute phase proteins in early pregnancy and risk of autism spectrum disorders in offspring. Transl Psychiatry. 2022 Apr 7;12(1):148. doi: 10.1038/s41398-022-01907-z. PMID: 35393396.

  198. Lin PC, Liang CS, Tsai CK, Tsai SJ, Chen TJ, Bai YM, Chen MH (2022): Associations of a family history of lupus with the risks of lupus and major psychiatric disorders in first-degree relatives. QJM. 2022 Jun 27:hcac153. doi: 10.1093/qjmed/hcac153. PMID: 35758635.

  199. Koutra, Margetaki, Kampouri, Kyriklaki, Roumeliotaki, Vafeiadi, Bitsios, Kogevinas, Chatzi (2022) Maternal sleep disturbances during late pregnancy and child neuropsychological and behavioral development in early childhood. Eur Child Adolesc Psychiatry. 2022 Aug 4. doi: 10.1007/s00787-022-02053-z. PMID: 35927528. n = 638 Mutter-Kind-Paare / mother-child pairs

  200. Levie, Bath, Guxens, Korevaar, Dineva, Fano, Ibarluzea, Llop, Murcia, Rayman, Sunyer, Peeters, Tiemeier (2020): Maternal Iodine Status During Pregnancy Is Not Consistently Associated with Attention-Deficit Hyperactivity Disorder or Autistic Traits in Children. J Nutr. 2020 Jun 1;150(6):1516-1528. doi: 10.1093/jn/nxaa051. PMID: 32171006; PMCID: PMC7269752.

  201. Gao X, Zhao Y, Wang N, Yang L. (2022): Migration modulates the prevalence of ASD and ADHD: a systematic review and meta-analysis. BMC Psychiatry. 2022 Jun 13;22(1):395. doi: 10.1186/s12888-022-04037-4. PMID: 35698047; PMCID: PMC9195277. METASTUDIE